扫码下载APP

您的位置

学者详情
Yang, Wei

Yang, Wei

江苏省人民医院

3

H指数

14

论文数

25

被引数

H指数、论文数、被引数仅支持在APP上查看和修改扫描二维码即可下载APP

Yang, Wei,现任职于江苏省人民医院,曾任职于中国中医科学院机构,个人H指数为3,累计发表论文14篇,论文总被引数累计25次,主要研究方向涵盖生物化学,遗传学和分子生物学等领域,在Journal of Hepatology、Journal of Translational Medicine和Academic Radiology顶级期刊累计发表4次

访客XXX

可下载论论APP查看访客

本人可编辑资料

学者资料仅支持在APP上编辑扫描二维码即可编辑

  • 发表期刊
  • 资讯动态
  • 发表论文
  • 引用关系
CRAFITY评分:接受免疫治疗的肝细胞癌患者预后预测的新指标

The CRAFITY score: A new guidepost for prognosis prediction in patients with hepatocellular carcinoma undergoing immunotherapy

江苏省人民医院

2022

被引数:1

Journal of Hepatology

周卫忠

从动态模块网络预测慢性肝病患者的肝细胞癌风险

Prediction of hepatocellular carcinoma risk in patients with chronic liver disease from dynamic modular networks

中国中医科学院

2021

被引数:1

Journal of Translational Medicine

苏式兵

Chronic liver disease,Cirrhosis,HCC risk,Dynamic modular networks,Chronic hepatitis B (CHB),Hepatocellular carcinoma (HCC),Sequential allosteric modules
经动脉化疗栓塞联合阿帕替尼联合或不联合卡马西单抗治疗不能切除的肝细胞癌:一项双中心倾向评分匹配研究

Transarterial chemoembolization plus apatinib with or without camrelizumab for unresected hepatocellular carcinoma: A two-center propensity score matching study

江苏省人民医院

2022

被引数:0

Frontiers in Oncology

Shi, Haibin

apatinib,hepatocellular carcinoma,immunotherapy,PD-1,prognosis,transarterial chemoembolization
经动脉化疗栓塞联合分子靶向治疗的门静脉肿瘤血栓患者肝细胞癌预后评价——ABPS 评分的开发和验证

Prognostic Evaluation for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Patients Treated with Transarterial Chemoembolization Plus Molecular Targeted Therapies—Development and Validation of the ABPS Score

安徽医科大学

2024

被引数:0

Academic Radiology

Lv, Weifei Fu

Hepatocellular carcinoma,Prognosis,Score,TACE,Targeted therapy
MicroRNA-32-5p通过靶向SMAD家族3抑制肺腺癌上皮间质转化和转移

MicroRNA-32-5p inhibits epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting SMAD family 3

江苏省人民医院

2021

被引数:11

Journal of Cancer

Shi, Haibin

Invasion,MicroRNA-32-5p,Migration,Non-small cell lung cancer,SMAD3
胰腺癌行胆道引流致恶性胆道梗阻患者的生存预测:COMBO-PaS模型

Survival prediction for patients with malignant biliary obstruction caused by pancreatic cancer undergoing biliary drainage: the COMBO-PaS model

江苏省人民医院

2022

被引数:0

Surgical Endoscopy

Shi, Haibin

Biliary obstruction,Pancreatic cancer,Percutaneous biliary drainage,Prognostic prediction,Survival

引用关系明细仅支持在APP查看扫描二维码即可下载

全部资讯信息仅支持在APP上查看扫描二维码即可下载APP